Summary
We describe two patients with severe thrombocytopenia and bleeding tendency related to treatment with glibenclamide (short-acting sulfonylurea). To the best of our knowledge, thrombocytopenic purpura associated with this medication has been reported only twice previously. We suggest that platelet count should be carried out early after initiating glibenclamide treatment and every 3 months thereafter.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- WBC:
-
white blood cell
- LE:
-
lupus erythematosus
- fL:
-
femtoliter
References
Crim JA, Molony BA, Gundersen K (1975) The effect of Micronase (Glyburide) on thyroid function and platelet count in maturity onset diabetes. In: Rifkin H (ed) Micronase — pharmacologycol and clinical evaluation. Excerpta Medica, Amsterdam
Duncan LJP, Baird JD, Dunlop DM (1956) A clinical trial of BZ55. Br Med J 2:433–439
Flenker I, Neuhausen P, Ricken D, et al. (1977) Akute thrombozytopenische Purpura nach Glibenclamide Medikation. Med Welt 28:127–128
Grace, WJ (1959) Thrombocytopenia in a patient taking chlorpropamide. N Engl J Med 260:711–712
Larner J (1985) Insulin and oral hypoglycemic drugs; glucagon. In: Goodman Gilman A, Goodman LS, Wall TW, Murad F (eds) The pharmacological basis of therapeutics 7th edn. Macmillan, New York, pp 1506–1507
Phemister JC (1957) Thrombocytopenia and leucopenia following carabutamide. Br Med J 1:199–204
Wintrobe MM (1967) The purpuras. In: Wintrobe MM (ed) Clinical hematology, 6th edn. Lea and Febiger, Philadelphia, pp 886–934
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Israeli, A., Matzner, Y., Or, R. et al. Glibenclamide causing thrombocytopenia and bleeding tendency: Case reports and a review of the literature. Klin Wochenschr 66, 223–224 (1988). https://doi.org/10.1007/BF01728201
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01728201